Research Article

Arum conophalloides Aqueous Extract Induced Hepatotoxicity in Rat; Histopathological, Biochemical, and mir-122 Assessments

Author(s): Amin Derakhshanfar, Javad Moayedi *, Mahjoob Vahedi and Abouzar Valizadeh

Volume 9 , Issue 3 , 2020

Page: [224 - 231] Pages: 8

DOI: 10.2174/2211536608666191016142400


Background: Arum conophalloides (A. conophalloides) is a wild edible delicate plant, widely used in traditional medicine.

Objective: This study aimed to examine the effects of A. conophalloides extracts on biochemical, molecular, and histopathological changes in the rat.

Methods: Fifty adult male Sprague-Dawley rats were divided into 5 groups (10 each) as follows: G1 or control, received distilled water; G2 and G3, treated with the aqueous extract at doses of 200 and 400 mg/kg; G4 and G5, treated with the hydroalcoholic extract at doses of 200 and 400 mg/kg. Prior to and at the end of the experiments, the serum levels of biochemistry parameters and the relative expression of miR-122 were assessed. Moreover, the liver and kidney tissues were examined microscopically.

Results: Liver and kidney tissues showed normal structure in all groups. There were no significant changes in biochemical indices or the expression of miR-122 in the extract-treated groups at the dose of 200 mg/kg. However, the group that received the aqueous extract at the dose of 400 mg/kg exhibited a significantly lower level of HDL, LDL, ALT, and ALP in comparison to the control. Additionally, miR-122 expression in this group exhibited a 10-fold increase (P=0.009).

Conclusion: The serum level of hepatocyte-specific miR-122 will be more helpful in detecting hepatic changes in early stages than ALT and AST activity or histopathological evaluations of liver sections. Our findings highlight the potential hepatotoxicity of A. conophalloides aqueous extract in a rat model.

Keywords: Arum conophalloides, hepatotoxicity, miR-122, rat, histopathological, HDL, ALT, AST.

Graphical Abstract
Haghighi H. Essential oil of the leaves of Arum conophalloides (Araceae) from Iran. Indian J Pharm Sci 2016; 12(3): 11-6.
Kaval İ, Behçet L, Çakilcioğlu U. Survey of wild food plants for human consumption in Geçitli (Hakkari, Turkey). Indian J Tradit Knowl 2015; 14(2): 183-90.
Mosaddegh M, Naghibi F, Moazzeni H, Pirani A, Esmaeili S. Ethnobotanical survey of herbal remedies traditionally used in Kohghiluyeh va Boyer Ahmad province of Iran. J Ethnopharmacol 2012; 141(1): 80-95.
[] [PMID: 22366675]
Erbay MŞ, Anıl S, Melikoğlu G. Plants used as painkiller in traditional treatment in Turkey-II Headache. Marmara Pharm J 2018; 22(1): 29-36.
Seifi Zangeneh M, Rafieirad M, Sazgar H. The effect of Kardeh (Biarum Bovei) hydro-alcoholic extract on pain threshold in STZ induced diabetic rats. J Herbal Drugs 2015; 6(3): 137-42.
Hosseinzadeh S, Jafarikukhdan A, Hosseini A, Armand R. The application of medicinal plants in traditional and modern medicine: a review of Thymus vulgaris. Int J Clin Med 2015; 6(9): 635-42.
Atanasov AG, Waltenberger B, Pferschy-Wenzig E-M, et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv 2015; 33(8): 1582-614.
[] [PMID: 26281720]
Chikezie PC, Ojiako OA. Herbal medicine: yesterday, today and tomorrow. Altern Integr Med 2015; 4(3): 195-9.
Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evid Based Complement Alternat Med 2015; 2015: 316706
[] [PMID: 25838831]
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177.
[] [PMID: 24454289]
Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol 2013; 75(3): 630-6.
[] [PMID: 22831551]
Guan Y-S, He Q. Plants consumption and liver health. Evid Based Complement Alternat Med 2015; 2015(9): 824185
[PMID: 26221179]
Licata A, Macaluso FS, Craxì A. Herbal hepatotoxicity: a hidden epidemic. Intern Emerg Med 2013; 8(1): 13-22.
[] [PMID: 22477279]
Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut 2018; 67(1): 6-19.
[] [PMID: 29122851]
Malakouti M, Kataria A, Ali SK, Schenker S. Elevated liver enzymes in asymptomatic patients - what should I do? J Clin Transl Hepatol 2017; 5(4): 394-403.
[] [PMID: 29226106]
Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014; 20(2): 475-85.
[PMID: 24574716]
Fallatah HI. Noninvasive biomarkers of liver fibrosis: an overview. Adv Hepatol 2014; 2014(1): 357287
Halász T, Horváth G, Pár G, et al. miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan. World J Gastroenterol 2015; 21(25): 7814-23.
[] [PMID: 26167081]
Laterza OF, Scott MG, Garrett-Engele PW, Korenblat KM, Lockwood CM. Circulating miR-122 as a potential biomarker of liver disease. Biomarkers Med 2013; 7(2): 205-10.
[] [PMID: 23547815]
Wang K, Yuan Y, Cho J-H, McClarty S, Baxter D, Galas DJ. Comparing the MicroRNA spectrum between serum and plasma. PLoS One 2012; 7(7): e41561
[] [PMID: 22859996]
Roderburg C, Benz F, Vargas Cardenas D, et al. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int 2015; 35(4): 1172-84.
[] [PMID: 25039534]
Hu J, Xu Y, Hao J, Wang S, Li C, Meng S. MiR-122 in hepatic function and liver diseases. Protein Cell 2012; 3(5): 364-71.
[] [PMID: 22610888]
Zhang Y, Jia Y, Zheng R, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010; 56(12): 1830-8.
[] [PMID: 20930130]
Starkey Lewis PJ, Dear J, Platt V, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011; 54(5): 1767-76.
[] [PMID: 22045675]
Wang Y-L, Yu W. Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions. PeerJ 2018; 6: e5218
[] [PMID: 30013851]
Willeit P, Skroblin P, Kiechl S, Fernández-Hernando C, Mayr M. Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? Eur Heart J 2016; 37(43): 3260-6.
[] [PMID: 27099265]
Sharapova T, Devanarayan V, LeRoy B, et al. Evaluation of miR-122 as a serum biomarker for hepatotoxicity in investigative rat toxicology studies. Vet Pathol 2016; 53(1): 211-21.
[] [PMID: 26123229]
Starckx S, Batheja A, Verheyen GR, et al. Evaluation of miR-122 and other biomarkers in distinct acute liver injury in rats. Toxicol Pathol 2013; 41(5): 795-804.
[] [PMID: 23143187]
Antoine DJ, Dear JW, Lewis PS, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 2013; 58(2): 777-87.
[] [PMID: 23390034]
Park H-K, Jo W, Choi H-J, et al. Time-course changes in the expression levels of miR-122, -155, and -21 as markers of liver cell damage, inflammation, and regeneration in acetaminophen-induced liver injury in rats. J Vet Sci 2016; 17(1): 45-51.
[] [PMID: 27051339]
Peng X, Li Q, Lu S, He X, Yu S, Zhang Z, et al. The plasma miR-122 basal levels respond to circulating catecholamine in rats. bioRxiv 2018; 2018(1): 257402
Amr KS, Elmawgoud AHA, Elazeem ERA, Ezzat WM. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma. Genes Dis 2017; 4(4): 215-21.
[] [PMID: 30258925]
Yuan X, Waterworth D, Perry JR, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 2008; 83(4): 520-8.
[] [PMID: 18940312]
Robles-Díaz M, Medina-Caliz I, Stephens C, Andrade RJ, Lucena MI. Biomarkers in DILI: one more step forward. Front Pharmacol 2016; 7: 267.
[] [PMID: 27597831]
Christie WW. 13‐Phenyltridec‐9‐enoic and 15‐phenylpentadec‐9‐enoic acids in Arum maculatum seed oil. Eur J Lipid Sci Technol 2003; 105(12): 779-80.
Kite GC. The floral odour of Arum maculatum. Biochem Syst Ecol 1995; 23(4): 343-54.
Salik S, Alpinar K, Imre S. Fatty acid composition of the seed oil of Arum italicum miller. J Food Lipids 2002; 9(2): 95-103.
El-Desouky SK, Kim KH, Ryu SY, Eweas AF, Gamal-Eldeen AM, Kim YK. A new pyrrole alkaloid isolated from Arum palaestinum Boiss. and its biological activities. Arch Pharm Res 2007; 30(8): 927-31.
[] [PMID: 17879743]
Al-Qudah M. Histological and biochemical studies on liver of female rats treated with different concentrations of ethanolic extract of Arum palaestinum. J Appli Environ Biol Sci 2016; 6(7): 7-16.

© 2022 Bentham Science Publishers | Privacy Policy